Seoul [South Korea], May 12 (ANI/Global Economic): NeoImmuneTech said on the 11th that it has obtained the approval for a phase 2 clinical trial plan that concomitant administration of US Merck's immune checkpoint inhibitor Keytruda and its T-cell amplifier NT-I7 to patients with glioblastom
Washington D.C. [USA], Jan 16 (ANI): Researchers have figured out a new method to bypass the blood-brain barrier in situations where it begins to play a counterproductive role by expelling the immune system cell through its drainage system.